Daiwa increases holding of Hengrui Medicine (01276.HK) by approximately 258,360 shares, with a price of approximately 57.79 Hong Kong dollars per share.

According to the Smart Finance and Economics App, as disclosed by the latest data from the Hong Kong Stock Exchange, on May 30th, Morgan Stanley increased its holdings of CSPC Pharmaceutical Group Ltd. (01276.HK) by 2.583 million shares at a price of 57.7923 Hong Kong dollars per share, with a total amount of approximately 149 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 24.2192 million shares, and the latest shareholding ratio is 10.78%.